跳至主要内容
临床试验/NCT05820451
NCT05820451招募中不适用

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Abiomed Inc.0 个研究点目标入组 330 人开始时间: 2022年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Abiomed Inc.
入组人数
330
主要终点
Primary Endpoint Right Sided Impella

研究概览

简要总结

The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Left-sided Impella with bicarbonate in the purge

排除标准

  • Known LV thrombus
  • Right Sided Impella
  • Inclusion Criteria:
  • Right-sided Impella with bicarbonate in the purge
  • Exclusion Criteria:
  • Known pulmonary thromboemboli
  • Known DVT

结局指标

主要结局

Primary Endpoint Right Sided Impella

时间窗: From hospital admission until hospital discharge, average 5 days

Rate of heiarchical composite of pulmonary thromboemboli and deep vein thrombosis (DVT)

Primary Endpoint Left Sided Impella

时间窗: From hospital admission until hospital discharge, average 5 days

Rate of heiarchical composite of stroke, transient ischemic attack (TIA), left ventricular (LV) thrombus

次要结局

未报告次要终点

研究者

发起方
Abiomed Inc.
申办方类型
Industry
责任方
Sponsor

相似试验